Literature DB >> 29038051

Integrated approach reveals diet, APOE genotype and sex affect immune response in APP mice.

Kyong Nyon Nam1, Cody M Wolfe1, Nicholas F Fitz1, Florent Letronne1, Emilie L Castranio1, Anais Mounier1, Jonathan Schug2, Iliya Lefterov3, Radosveta Koldamova4.   

Abstract

Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder that is influenced by genetic and environmental risk factors, such as inheritance of ε4 allele of APOE (APOE4), sex and diet. Here, we examined the effect of high fat diet (HFD) on amyloid pathology and expression profile in brains of AD model mice expressing human APOE isoforms (APP/E3 and APP/E4 mice). APP/E3 and APP/E4 mice were fed HFD or Normal diet for 3months. We found that HFD significantly increased amyloid plaques in male and female APP/E4, but not in APP/E3 mice. To identify differentially expressed genes and gene-networks correlated to diet, APOE isoform and sex, we performed RNA sequencing and applied Weighted Gene Co-expression Network Analysis. We determined that the immune response network with major hubs Tyrobp/DAP12, Csf1r, Tlr2, C1qc and Laptm5 correlated significantly and positively to the phenotype of female APP/E4-HFD mice. Correspondingly, we found that in female APP/E4-HFD mice, microglia coverage around plaques, particularly of larger size, was significantly reduced. This suggests altered containment of the plaque growth and sex-dependent vulnerability in response to diet. The results of our study show concurrent impact of diet, APOE isoform and sex on the brain transcriptome and AD-like phenotype.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  APOE genotype; APP mice; Alzheimer's disease; Diet; Microglia; Tyrobp/DAP12

Mesh:

Substances:

Year:  2017        PMID: 29038051      PMCID: PMC5714325          DOI: 10.1016/j.bbadis.2017.10.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  55 in total

Review 1.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

2.  RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.

Authors:  Iliya Lefterov; Jonathan Schug; Anais Mounier; Kyong Nyon Nam; Nicholas F Fitz; Radosveta Koldamova
Journal:  Neurobiol Dis       Date:  2015-06-10       Impact factor: 5.996

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Authors:  L M Refolo; B Malester; J LaFrancois; T Bryant-Thomas; R Wang; G S Tint; K Sambamurti; K Duff; M A Pappolla
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

Review 5.  Epidemiology of Alzheimer disease.

Authors:  Christiane Reitz; Carol Brayne; Richard Mayeux
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

6.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy.

Authors:  Peng Yuan; Carlo Condello; C Dirk Keene; Yaming Wang; Thomas D Bird; Steven M Paul; Wenjie Luo; Marco Colonna; David Baddeley; Jaime Grutzendler
Journal:  Neuron       Date:  2016-05-18       Impact factor: 17.173

Review 7.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

Review 8.  Genetics of Alzheimer's disease.

Authors:  Rita Guerreiro; John Hardy
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

9.  RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers.

Authors:  Kyong Nyon Nam; Anais Mounier; Nicholas F Fitz; Cody Wolfe; Jonathan Schug; Iliya Lefterov; Radosveta Koldamova
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

10.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Nucleic Acids Res       Date:  2013-04-04       Impact factor: 16.971

View more
  10 in total

Review 1.  Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.

Authors:  Cutler T Lewandowski; Juan Maldonado Weng; Mary Jo LaDu
Journal:  Neurobiol Dis       Date:  2020-02-20       Impact factor: 5.996

Review 2.  The role of APOE in transgenic mouse models of AD.

Authors:  Deebika Balu; Aimee James Karstens; Efstathia Loukenas; Juan Maldonado Weng; Jason M York; Ana Carolina Valencia-Olvera; Mary Jo LaDu
Journal:  Neurosci Lett       Date:  2019-05-28       Impact factor: 3.046

3.  Genetic variability in response to amyloid beta deposition influences Alzheimer's disease risk.

Authors:  Dervis A Salih; Sevinc Bayram; Sebastian Guelfi; Regina H Reynolds; Maryam Shoai; Mina Ryten; Jonathan W Brenton; David Zhang; Mar Matarin; Juan A Botia; Runil Shah; Keeley J Brookes; Tamar Guetta-Baranes; Kevin Morgan; Eftychia Bellou; Damian M Cummings; Valentina Escott-Price; John Hardy
Journal:  Brain Commun       Date:  2019-10-10

4.  High-fat diet increases gliosis and immediate early gene expression in APOE3 mice, but not APOE4 mice.

Authors:  Nahdia S Jones; Katarina Q Watson; G William Rebeck
Journal:  J Neuroinflammation       Date:  2021-09-18       Impact factor: 8.322

5.  APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma.

Authors:  Xu Lin; Jing Zhang; Ru-Hua Zhao; Wen-Jing Zhang; Jing-Fang Wu; Gang Xue
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207

Review 6.  Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine.

Authors:  Marina A Lynch
Journal:  Front Aging Neurosci       Date:  2022-03-31       Impact factor: 5.750

Review 7.  The effect of dietary fat consumption on Alzheimer's disease pathogenesis in mouse models.

Authors:  Anna Amelianchik; Lauren Sweetland-Martin; Erin H Norris
Journal:  Transl Psychiatry       Date:  2022-07-22       Impact factor: 7.989

8.  Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer's disease.

Authors:  Nicholas F Fitz; Kyong Nyon Nam; Cody M Wolfe; Florent Letronne; Brittany E Playso; Bistra E Iordanova; Takashi D Y Kozai; Richard J Biedrzycki; Valerian E Kagan; Yulia Y Tyurina; Xianlin Han; Iliya Lefterov; Radosveta Koldamova
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

9.  APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice.

Authors:  Amy Christensen; Christian J Pike
Journal:  FASEB J       Date:  2018-12-03       Impact factor: 5.834

10.  ABCA1 haplodeficiency affects the brain transcriptome following traumatic brain injury in mice expressing human APOE isoforms.

Authors:  Emilie L Castranio; Cody M Wolfe; Kyong Nyon Nam; Florent Letronne; Nicholas F Fitz; Iliya Lefterov; Radosveta Koldamova
Journal:  Acta Neuropathol Commun       Date:  2018-07-26       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.